{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:23:09Z","timestamp":1775143389941,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.soc.2018.02.012","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T23:22:47Z","timestamp":1529536967000},"page":"443-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Patient Selection for Cytoreductive Surgery"],"prefix":"10.1016","volume":"27","author":[{"given":"Travis E.","family":"Grotz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith F.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.soc.2018.02.012_bib1","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.soc.2018.02.012_bib2","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2018.02.012_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","article-title":"Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program","volume":"149","author":"Jafari","year":"2014","journal-title":"JAMA Surg"},{"issue":"11","key":"10.1016\/j.soc.2018.02.012_bib4","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/bjs.5863","article-title":"Learning curve of combined modality treatment in peritoneal surface disease","volume":"94","author":"Smeenk","year":"2007","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.soc.2018.02.012_bib5","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1245\/s10434-014-4111-x","article-title":"Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies","volume":"22","author":"Polanco","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2018.02.012_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1245\/s10434-015-4892-6","article-title":"Predictors of severe morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis","volume":"23","author":"Simkens","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.soc.2018.02.012_bib7","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","article-title":"Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients","volume":"57","author":"Baratti","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.soc.2018.02.012_bib8","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1245\/s10434-013-3053-z","article-title":"Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality","volume":"20","author":"Votanopoulos","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.soc.2018.02.012_bib9","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1245\/s10434-013-3049-8","article-title":"Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status","volume":"20","author":"Ihemelandu","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2018.02.012_bib10","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1245\/s10434-013-3223-z","article-title":"Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: outcomes from the ACS NSQIP database","volume":"21","author":"Bartlett","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2018.02.012_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/bja\/aen401","article-title":"Smoking and alcohol intervention before surgery: evidence for best practice","volume":"102","author":"Tonnesen","year":"2009","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.soc.2018.02.012_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12630-011-9652-x","article-title":"Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis","volume":"59","author":"Wong","year":"2012","journal-title":"Can J Anaesth"},{"issue":"3","key":"10.1016\/j.soc.2018.02.012_bib13","article-title":"Interventions for preoperative smoking cessation","author":"Thomsen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.soc.2018.02.012_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jamcollsurg.2010.10.016","article-title":"Perioperative use of arginine-supplemented diets: a systematic review of the evidence","volume":"212","author":"Drover","year":"2011","journal-title":"J\u00a0Am Coll Surg"},{"issue":"10","key":"10.1016\/j.soc.2018.02.012_bib15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.nut.2012.01.017","article-title":"Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk","volume":"28","author":"Jie","year":"2012","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.soc.2018.02.012_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jss.2015.08.003","article-title":"Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates","volume":"200","author":"Dineen","year":"2016","journal-title":"J\u00a0Surg Res"},{"issue":"2","key":"10.1016\/j.soc.2018.02.012_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000658-199402000-00001","article-title":"Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon","volume":"219","author":"Sugarbaker","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2018.02.012_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"20","key":"10.1016\/j.soc.2018.02.012_bib19","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2018.02.012_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/IGC.0000000000000327","article-title":"Prognostic significance of Sugarbaker's peritoneal cancer index for the operability of ovarian carcinoma","volume":"25","author":"Lampe","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"10.1016\/j.soc.2018.02.012_bib21","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1245\/s10434-015-4446-y","article-title":"A\u00a0simplified preoperative assessment predicts complete cytoreduction and outcomes in patients with low-grade mucinous adenocarcinoma of the appendix","volume":"22","author":"Dineen","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2018.02.012_bib22","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-013-3224-y","article-title":"Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites","volume":"21","author":"Randle","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2018.02.012_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1457496915598759","article-title":"Palliative surgery for pseudomyxoma peritonei","volume":"105","author":"Funder","year":"2016","journal-title":"Scand J Surg"},{"issue":"12","key":"10.1016\/j.soc.2018.02.012_bib24","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/DCR.0b013e3182a62b0d","article-title":"Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved","volume":"56","author":"Dayal","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.soc.2018.02.012_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jso.20107","article-title":"Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix","volume":"87","author":"Carmignani","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2018.02.012_bib26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1245\/s10434-012-2627-5","article-title":"Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin","volume":"20","author":"Wagner","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2018.02.012_bib27","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1245\/s10434-007-9393-9","article-title":"Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Baratti","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2018.02.012_bib28","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1245\/s10434-014-4335-9","article-title":"Improved survival with anti-VEGF therapy in the treatment of unresectable appendiceal epithelial neoplasms","volume":"22","author":"Choe","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2018.02.012_bib29","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1245\/s10434-014-3713-7","article-title":"Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis","volume":"21","author":"Ceelen","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2018.02.012_bib30","first-page":"3","article-title":"Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"7","author":"Cummins","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.soc.2018.02.012_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1477-7819-12-270","article-title":"Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"12","author":"Jayakrishnan","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2018.02.012_bib32","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jso.23924","article-title":"Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: a multi-institutional analysis","volume":"111","author":"Tabrizian","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2018.02.012_bib33","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1245\/s10434-015-4958-5","article-title":"Laparoscopy is safe and accurate to evaluate peritoneal surface metastasis prior to cytoreductive surgery","volume":"23","author":"Marmor","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2018.02.012_bib34","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1245\/s10434-017-5938-8","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for moderately and poorly differentiated appendiceal adenocarcinoma: survival outcomes and patient selection","volume":"24","author":"Grotz","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2018.02.012_bib35","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","article-title":"Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study","volume":"22","author":"Go\u00e9r\u00e9","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2018.02.012_bib36","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1245\/s10434-014-3506-z","article-title":"A\u00a0simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases","volume":"21","author":"Elias","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2018.02.012_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology","volume":"14","author":"Esquivel","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2018.02.012_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ejso.2012.03.001","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study","volume":"38","author":"Cashin","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.soc.2018.02.012_bib39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejso.2010.05.007","article-title":"Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends","volume":"36","author":"Maggiori","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2018.02.012_bib40","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1245\/s10434-013-3328-4","article-title":"Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin","volume":"21","author":"Winer","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2018.02.012_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jso.23610","article-title":"Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate","volume":"110","author":"Cashin","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2018.02.012_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.23784","article-title":"Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology","volume":"111","author":"van Oudheusden","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2018.02.012_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jso.21169","article-title":"Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis","volume":"99","author":"Pelz","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.soc.2018.02.012_bib44","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/1471-2407-10-689","article-title":"Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin","volume":"10","author":"Pelz","year":"2010","journal-title":"BMC Cancer"},{"issue":"13","key":"10.1016\/j.soc.2018.02.012_bib45","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1245\/s10434-014-3798-z","article-title":"The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis","volume":"21","author":"Esquivel","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2018.02.012_bib46","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1245\/s10434-009-0866-x","article-title":"Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"17","author":"Chua","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.soc.2018.02.012_bib47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/DCR.0000000000000589","article-title":"Intraperitoneal-free cancer cells represent a major prognostic factor in colorectal peritoneal carcinomatosis","volume":"59","author":"Trilling","year":"2016","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.soc.2018.02.012_bib48","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/COC.0b013e3182a0e867","article-title":"Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma","volume":"38","author":"Pillai","year":"2015","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.soc.2018.02.012_bib49","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","article-title":"The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"23","author":"Kusamura","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2018.02.012_bib50","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/his.12807","article-title":"Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma","volume":"68","author":"Krasinskas","year":"2016","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.soc.2018.02.012_bib51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MNM.0000000000000649","article-title":"The role of 18F-FDG-PET\/ceCT in peritoneal mesothelioma","volume":"38","author":"Dubreuil","year":"2017","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1016\/j.soc.2018.02.012_bib52","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2018.02.012_bib53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.23633","article-title":"Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial","volume":"110","author":"Rudloff","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2018.02.012_bib54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jso.21519","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and\/or peritoneal carcinomatosis: results from a Chinese center","volume":"101","author":"Yang","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2018.02.012_bib55","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","article-title":"Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?","volume":"23","author":"Chia","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2018.02.012_bib56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4251\/wjgo.v2.i2.85","article-title":"Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer","volume":"2","author":"Yonemura","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.soc.2018.02.012_bib57","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C","article-title":"Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery","volume":"79","author":"Fujimoto","year":"1997","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.soc.2018.02.012_bib58","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.soc.2018.02.012_bib59","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N\u00a0Engl J Med"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320718300243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320718300243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:01:42Z","timestamp":1760961702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320718300243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1055320718300243"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2018.02.012","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Selection for Cytoreductive Surgery","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2018.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}